Biotechnological applications for surface‐engineered bacteria

H Wernérus, S Ståhl - Biotechnology and applied biochemistry, 2004 - Wiley Online Library
Display of heterologous proteins on the surface of micro‐organisms, enabled by means of
recombinant DNA technology, has become an increasingly popular strategy in microbiology …

Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner

EMF Mauriello, LH Duc, R Isticato, G Cangiano… - Vaccine, 2004 - Elsevier
We report the use of CotC, a major component of the Bacillus subtilis spore coat, as a fusion
partner for the expression of two heterologous antigens on the spore coat. Recombinant …

Mucosal and Cellular Immune Responses Elicited by Recombinant Lactococcus lactis Strains Expressing Tetanus Toxin Fragment C

K Robinson, LM Chamberlain, MC Lopez… - Infection and …, 2004 - Am Soc Microbiol
The mucosal and cellular responses of mice were studied, following mucosal-route
administration of recombinant Lactococcus lactis expressing tetanus toxin fragment C …

Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria

C Grangette, H Müller-Alouf, P Hols… - Infection and …, 2004 - Am Soc Microbiol
The potential of recombinant lactic acid bacteria (LAB) to deliver heterologous antigens to
the immune system and to induce protective immunity has been best demonstrated by using …

Oral priming of mice by recombinant spores of Bacillus subtilis

A Ciabattini, R Parigi, R Isticato, MR Oggioni, G Pozzi - Vaccine, 2004 - Elsevier
Recombinant Bacillus subtilis spores were employed as a vaccine delivery system in a
heterologous mucosal priming-parenteral boosting vaccination strategy in the mouse model …

In Vivo Phage Display to Identify M Cell-Targeting Ligands

LM Higgins, I Lambkin, G Donnelly, D Byrne… - Pharmaceutical …, 2004 - Springer
Purpose. The purpose of this study was to use in vivo phage display screening technology to
identify novel lead peptides that target delivery to M cells and to follicle-associated …

Progress toward development of an inhalation vaccine against botulinum toxin

JB Park, LL Simpson - Expert Review of Vaccines, 2004 - Taylor & Francis
The looming threat of bioterrorism has enhanced interest in the development of vaccines
against agents such as botulinum toxin. This in turn has stimulated efforts to create vaccines …

Expression and Immunogenicity of a Recombinant Diphtheria Toxin Fragment A in Streptococcus gordonii

CW Lee, SF Lee, SA Halperin - Applied and environmental …, 2004 - Am Soc Microbiol
ABSTRACT A nontoxic mutant diphtheria toxin fragment A (DTA) was genetically fused in
single, double, or triple copy to the major surface protein antigen P1 (SpaP) and surface …

Expression of a functional single-chain Fv antibody on the surface of Streptococcus gordonii

B Giomarelli, T Maggi, J Younson, C Kelly… - Molecular …, 2004 - Springer
Gram-positive bacterium Streptococcus gordonii, a human oral commensal, was engineered
to display a single-chain Fv (scFv) antibody fragment at the cell surface. The previously …

[PDF][PDF] LA VACUNA CONTRA LA HEPATITIS B

CFA ORTIZ - Fundamentos y casos exitosos de la biotecnología … - academia.edu
El uso de vacunas desde principios del siglo pasado, y la introducción de los antibióticos y
de las prácticas de higiene modernas unas cuantas décadas después, han contribuido …